Mind Medicine (MindMed) Inc.
MNMD
$6.59
$0.203.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 40.75% | -22.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.94% | 1.37% | |||
| Operating Income | -30.94% | -1.37% | |||
| Income Before Tax | -153.88% | -133.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -153.88% | -133.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -153.88% | -133.75% | |||
| EBIT | -30.94% | -1.37% | |||
| EBITDA | -30.94% | -1.37% | |||
| EPS Basic | -135.71% | -115.72% | |||
| Normalized Basic EPS | -135.61% | -50.41% | |||
| EPS Diluted | -51.07% | -7.18% | |||
| Normalized Diluted EPS | -142.68% | -52.94% | |||
| Average Basic Shares Outstanding | 7.73% | 8.34% | |||
| Average Diluted Shares Outstanding | 4.60% | 6.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||